These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1718440)

  • 1. Long-term plasma exchange in a case of Refsum's disease.
    Leppert D; Schanz U; Burger J; Gmür J; Blau N; Waespe W
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):82-4. PubMed ID: 1718440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).
    Harari D; Gibberd FB; Dick JP; Sidey MC
    J Neurol Neurosurg Psychiatry; 1991 Jul; 54(7):614-7. PubMed ID: 1716665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange for Refsum's disease.
    Gibberd FB
    Transfus Sci; 1993 Jan; 14(1):23-6. PubMed ID: 10150979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A child with Refsum's disease: successful treatment with diet and plasma exchange.
    Dickson N; Mortimer JG; Faed JM; Pollard AC; Styles M; Peart DA
    Dev Med Child Neurol; 1989 Feb; 31(1):92-7. PubMed ID: 2465931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of plasma phytanic acid levels in adults.
    Britton TC; Gibberd FB; Clemens ME; Billimoria JD; Sidey MC
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):891-4. PubMed ID: 2475586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heredopathia atactica polyneuritiformis (Refsum's disease). Experiences of dietary treatment and plasmapheresis.
    Lundberg A; Lilja LG; Lundberg PO; Try K
    Eur Neurol; 1972; 8(6):309-24. PubMed ID: 4117669
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease).
    Eldjarn L; Try K; Stokke O
    Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999
    [No Abstract]   [Full Text] [Related]  

  • 10. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients.
    Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heredopathia atactica polyneuritiformis: Refsum's disease.
    Gibberd FB; Billimoria JD; Goldman JM; Clemens ME; Evans R; Whitelaw MN; Retsas S; Sherratt RM
    Acta Neurol Scand; 1985 Jul; 72(1):1-17. PubMed ID: 2413704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment.
    Refsum S
    Arch Neurol; 1981 Oct; 38(10):605-6. PubMed ID: 6170281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
    Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
    J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):245-50. PubMed ID: 6157716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heredopathia atactica polyneuritiformis (Refsum's disease): 2. Estimation of phytanic acid in foods.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):251-4. PubMed ID: 6157717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S
    Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytanic acid storage disease (Refsum's disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management.
    Weinstein R
    J Clin Apher; 1999; 14(4):181-4. PubMed ID: 10611628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refsum's syndrome. Heredopathia atactica polyneuritiformis.
    Nevin NC; Cumings JN; McKeown F
    Brain; 1967 Jun; 90(2):419-28. PubMed ID: 4165695
    [No Abstract]   [Full Text] [Related]  

  • 20. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease.
    Molzer B; Bernheimer H; Barolin GS; Höfinger E; Lenz H
    Clin Chim Acta; 1979 Jan; 91(2):133-40. PubMed ID: 83207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.